CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 1. Src kinase inhibitor PP1 inhibits [3H]thymidine incorporation by IGF-I. Proliferating 3T3-L1 cells were treated with or without 10 µM PP1 in the presence of 10 nM IGF-I (solid bars) or no hormone (open bars) for 24 h. [3H]thymidine (1 µCi/well) was added for the last 4 h. Cells were lysed in 0.33 M NaOH, an aliquot was removed for protein concentration determination, and DNA was precipitated with cold TCA. n = 6 wells (samples) per condition. This experiment was repeated once with identical results.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation